In patients with triple negative non-IBC who had PD-L1+ immune cells within the tumor, 44.4% (4 of 9) had partial responses, compared with 2.6% (1 of 39) for triple negative non-IBC and PD-L1– immune cells. Here, CD274 is linked to neoplasm.